Showing 3841-3850 of 5646 results for "".
- Nanoscope Therapeutics Wins 'Best of Show' Award at AAO Eyecelerator 2023https://modernod.com/news/nanoscope-therapeutics-wins-best-of-show-award-at-aao-eyecelerator-2023/2481955/Nanoscope Therapeutics was awarded the 'Best of Show in Retina' award at this year's American Academy of Ophthalmology (AAO) Eyecelerator conference held in San Francisco on Thursday, November 2, 2023. During the conference, Samuel Barone, MD, Nanoscope's chief
- Kiora’s KIO-301 Molecular Photoswitch Evaluated for Retinitis Pigmentosa in ABACUShttps://modernod.com/news/kioras-kio-301-molecular-photoswitch-evaluated-for-retinitis-pigmentosa-in-abacus/2481946/Kiora Pharmaceuticals announced topline results of a phase 1/2 clinical trial demonstrating proof-of-concept that KIO-301, the company’s first-in-class intravitreal (IVT) molecular photoswitch, has the potential to meaningfully improve vision in patients with retinitis pigmentosa (RP)
- Study of Sickle Retinopathy in Children Shows Similar Rate of Occurence as Adultshttps://modernod.com/news/study-of-sickle-retinopathy-in-children-shows-similar-rate-of-occurence-as-adults/2481945/The American Academy of Ophthalmology (AAO) announced the presentations of a study of sickle retinopathy, an age-dependent process that can develop in patients with sickle cell disease, of whom older patients are at substantially higher risk than younger patients. To learn more about ho
- Adverum’s Ixo-Vec for Wet AMD Evaluated in 3-Year Data from OPTIC Extension Studyhttps://modernod.com/news/adverums-ixo-vec-for-wet-amd-evaluated-in-3-year-data-from-optic-extension-study/2481951/Adverum Biotechnologies announced updated data from the OPTIC extension study of patients with wet age-related macular degeneration (AMD) and a summary of previously announced aflibercept protein levels from the LUNA study were presented during the Retina Subspecialty Day at AAO 2023 in
- GATHER2 Study Shows Izervay Monthly or Every Other Month Reduced GA Lesion Growth Through 2 Yearshttps://modernod.com/news/gather2-study-shows-izervay-monthly-or-every-other-month-reduced-ga-lesion-growth-through-2-years/2481944/Astellas Pharma announced results from the GATHER2 phase 3 clinical trial, demonstrating Izervay (avacincaptad pegol intravitreal solution) continued to reduce the rate of geographic atrophy (GA) lesion growth for both every month (EM) and every-other-month (EOM) dosing vs. sham through
- Topcon Introduces Tempo Perimeter at AAO 2023https://modernod.com/news/topcon-introduces-tempo-perimeter-at-aao-2023/2481942/Topcon announced that it is launching the Tempo Perimeter at the American Academy of Ophthalmology (AAO) meeting in San Francisco. Tempo is designed to provides fast, accurate, and comfortable visual field testing, according to Topcon. It is 39% faster than Stan
- Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officerhttps://modernod.com/news/ace-vision-group-names-rob-kissling-md-as-chief-medical-officer-1/2481938/Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology.
- Ora and BlindCAN Film Festival Unveil 'The Blind Canvas Project' Using AI to Visualize the Human Experience of Blindnesshttps://modernod.com/news/ora-and-blindcan-film-festival-unveil-the-blind-canvas-project-using-ai-to-visualize-the-human-experience-of-blindness/2481937/Ora and BlindCAN Film Festival announced the launch of 'The Blind Canvas Project,' which aims to use storytelling and generative artificial intelligence (AI) to foster a deeper understanding of the lives and experiences of people living with inherited retinal disease, childhood visua
- ADA and Genentech Launch Campaign to Raise Awareness and Address Inequity in Diabetes-Related Eye Diseasehttps://modernod.com/news/ada-and-genentech-launch-campaign-to-raise-awareness-and-address-inequity-in-diabetes-related-eye-disease/2481933/The American Diabetes Association (ADA) and Genentech, anchor partner of the ADA’s 'Health Equity Now' program, launched the 'Eye Pledge to Fight Diabetes.' This program encourages people with diabetes and their loved ones to get an annual eye exam, which have
- Centricity Vision Announces Commercial Launch of ZEPTOLink IOL Positioning System at AAOhttps://modernod.com/news/centricity-vision-announces-commercial-launch-of-zeptolink-iol-positioning-system-at-aao/2481931/Centricity Vision announced the commercial launch of its ZEPTOLink IOL Positioning System at the American Academy of Ophthalmology (AAO) annual meeting, November 3-6 in San Francisco. The new platform integrates the ZEPTO precision pulse capsulotomy technology with any phaco s